Current Evidence, May 2018, May 2018 Current Evidence
A critical appraisal of an article on therapy: Safety and efficacy of oral fusidic acid as a steroid-sparing agent in the treatment of lepra reactions: an assessor-blinded, randomized controlled clinical trial